Xiamen Amoytop Biotech Co., Ltd. (SHA:688278)

Xiamen Amoytop Biotech Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	528.07	371.82	412.96	301.24	285.42	197.16
Trading Asset Securities	290.04	289.96	257.08	270.78	196.38	268.22
Cash & Short-Term Investments	818.11	661.79	670.04	572.02	481.8	465.38
Cash Growth	24.83%	-1.23%	17.14%	18.73%	3.53%	126.04%
Accounts Receivable	695.96	808.52	441.02	223.05	206.28	185
Other Receivables	30.75	22.34	17.87	20.17	21.67	11.99
Receivables	726.71	830.86	458.9	243.22	227.94	196.99
Inventory	285.46	263.55	187.02	129.73	116.49	99.62
Other Current Assets	89.75	70.9	24.24	10.64	8.19	10.81
Total Current Assets	1,920	1,827	1,340	955.61	834.42	772.8
Property, Plant & Equipment	719.39	686.76	490.85	389.77	192.92	126.74
Other Intangible Assets	162.62	170.85	191.54	121.69	146.91	172.28
Long-Term Deferred Tax Assets	67.15	69.09	43.66	47.18	34.96	24.97
Long-Term Deferred Charges	236.03	221.2	176.7	229.25	169.14	78.24
Other Long-Term Assets	73.91	75.35	112.98	26.05	44.99	16.24
Total Assets	3,179	3,050	2,356	1,770	1,424	1,193
Accounts Payable	56.85	57.76	39.73	50.91	8.14	7.15
Accrued Expenses	128.56	233.75	244.46	159.55	120.4	60.94
Short-Term Debt	9.87	-	-	-	10	18.92
Current Portion of Leases	5.05	5.67	4.16	4.18	5.79	-
Current Income Taxes Payable	43.56	50.27	48.95	41.97	24.42	8.73
Current Unearned Revenue	62.19	63.13	60.05	7.23	5.18	3.34
Other Current Liabilities	39.43	10.06	6.31	4.05	3.3	15.86
Total Current Liabilities	345.5	420.63	403.66	267.89	177.23	114.94
Long-Term Leases	3.26	3.27	3.76	5.56	9.37	-
Long-Term Unearned Revenue	40.56	32.96	40.62	47.68	51.25	56.84
Long-Term Deferred Tax Liabilities	0.88	0.93	0.41	15.15	5.54	3.07
Other Long-Term Liabilities	39.65	39.31	31.25	25.99	19.53	17.48
Total Liabilities	429.84	497.1	479.69	362.27	262.91	192.33
Common Stock	406.8	406.8	406.8	406.8	406.8	406.8
Additional Paid-In Capital	426.98	413.14	397.04	397.04	397.04	397.04
Retained Earnings	1,916	1,733	1,073	603.76	357.42	196.56
Shareholders' Equity	2,749	2,553	1,876	1,408	1,161	1,000
Total Liabilities & Equity	3,179	3,050	2,356	1,770	1,424	1,193
Total Debt	18.17	8.94	7.92	9.74	25.16	18.92
Net Cash (Debt)	799.94	652.85	662.11	562.28	456.63	446.46
Net Cash Growth	23.48%	-1.40%	17.76%	23.14%	2.28%	206.23%
Net Cash Per Share	1.96	1.60	1.63	1.39	1.13	1.11
Filing Date Shares Outstanding	406.8	406.8	406.8	406.8	406.8	406.8
Total Common Shares Outstanding	406.8	406.8	406.8	406.8	406.8	406.8
Working Capital	1,575	1,406	936.53	687.72	657.19	657.86
Book Value Per Share	6.76	6.28	4.61	3.46	2.85	2.46
Tangible Book Value	2,587	2,382	1,685	1,286	1,014	828.12
Tangible Book Value Per Share	6.36	5.86	4.14	3.16	2.49	2.04
Buildings	-	291.61	135.53	118.65	21.31	22.03
Machinery	-	392.63	319.97	271.83	177.83	173.49
Construction In Progress	-	181.56	183.72	135.81	118	68.43

Source: S&P Global Market Intelligence. Standard template. Financial Sources.